发明名称 USE OF MAGNESIUM (MG2+) IN PREPARATION OF THERAPEUTIC COMPOSITION FOR TRANSFECTION OF POLYNUCLEOTIDE INTO CELL AND COMPOSITION USEFUL IN GENE THERAPY
摘要 PROBLEM TO BE SOLVED: To dramatically improve the transfection efficiency by adding magnesium to a therapeutic composition for transfecting a polynucleotide into a vertebrate tissue. SOLUTION: Magnesium(Mg2+) is added to a therapeutic composition for in vivo transfection of a polynucleotide into a cell. The magnesium is preferably magnesium chloride. The therapeutic composition preferably contains 0.1-100 mM, preferably 0.1-10 mM of the magnesium. The therapeutic composition is preferably used for administration to a target cell (preferably muscle) of a vertebrate. The composition preferably contains the polynucleotide and the concentration of the polynucleotide in the composition is preferably 0.1μg/ml to 20 mg/ml. Thereby, the composition useful for gene therapy, vaccination, etc., can be obtained.
申请公布号 JP2000143549(A) 申请公布日期 2000.05.23
申请号 JP19990278505 申请日期 1999.09.30
申请人 TRANSGENE SA;ASSOC FRANCAISE CONTRE LES MYOPATHIES 发明人 BRAUN SERGE
分类号 A61K9/08;A61K31/7088;A61K48/00;A61P43/00;(IPC1-7):A61K48/00;A61K31/708 主分类号 A61K9/08
代理机构 代理人
主权项
地址